Betting on Quality indicators to improve IBD surveillance outcome : all-in or one to pick ?
Inflammatory bowel disease (IBD) has a well-known increased risk of colorectal cancer (CRC).1 Therefore guidelines recommend meticulous endoscopic surveillance , aiming for a reduction in CRC-related death by detecting and treating lesions in a premalignant state. All guidelines currently suggest the use of chromo-endoscopy with targeted biopsies (ESGE and ECCO)2,3 or with random biopsies every 10 centimeter (SCENIC, ESGE and ECCO).2-4 Although several quality criteria have been defined for colorectal cancer screening programs, and for colonoscopy specifically 2 , there is still a need for validated quality indicators that should be met when performing an IBD surveillance endoscopy.